Your account is not claimed yet. You can sign up with ORCID to claim your account.

Wendy E Heywood

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

F1000Research

Developmental medicine and child neurology

Journal of inherited metabolic disease

Acta neuropathologica communications

University College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University College London Sep 30o 1998 - Nov 4o 2002

United Kingdom

PHD :: Institute of Child Health

Publications

Apostolos Papandreou, Ivan Doykov, Justyna Spiewak, Nikita Komarov, Stephanie Habermann, Manju A Kurian, Philippa B Mills, Kevin A Mills, Paul Gissen, Wendy E Heywood, null null
Niemann-Pick type C disease as proof-of-concept for intelligent biomarker panel selection in neurometabolic disorders. Developmental medicine and child neurology 64 (12) (2022)
Christina E Toomey, Wendy E Heywood, James R Evans, Joanne Lachica, Sarah N Pressey, Sandrine C Foti, Mesfer Al Shahrani, Karishma D'Sa, Iain P Hargreaves, Simon J R Heales, Michael Orford, Claire Troakes, Johannes Attems, Ellen Gelpi, Miklos Palkovits, Tammaryn Lashley, Steve M Gentleman, Tamas Revesz, Kevin A Mills, Sonia Gandhi
Mitochondrial dysfunction is a key pathological driver of early stage Parkinson's. Acta neuropathologica communications 10 (1) (2022)
Katharina Iwan, Nina Patel, Amanda J Heslegrave, Mina Borisova, Laura Lee, Rebecca Bower, Sara E Mole, Philippa B Mills, Henrik Zetterberg, Kevin A Mills, Paul Gissen, Wendy E Heywood
Cerebrospinal fluid neurofilament light chain levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment. F1000Research 10 (2021)
Katharina Iwan, Nina Patel, Amanda J Heslegrave, Mina Borisova, Laura Lee, Rebecca Bower, Sara E Mole, Philippa B Mills, Henrik Zetterberg, Kevin A Mills, Paul Gissen, Wendy E Heywood
Cerebrospinal fluid neurofilament light levels in CLN2 disease patients treated with enzyme replacement therapy normalise after two years on treatment. F1000Research 10 (2021)
Ivan Doykov, Jenny Hällqvist, Kimberly C Gilmour, Louis Grandjean, Kevin A Mills, Wendy E Heywood
'The long tail of Covid-19' - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research 9 (2020)
Nina Patel, Philippa B Mills, James E. Davison, Maureen Cleary, Paul Gissen, Blerida Banushi, Ivan Doykov, Megan Dorman, Kevin A Mills, Wendy E Heywood
Free urinary glycosylated hydroxylysine as an indicator of altered collagen degradation in the mucopolysaccharidoses. Journal of inherited metabolic disease 43 (2) (2019)

Wendy E Heywood.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Wendy E Heywood